Pramlintide and the treatment of diabetes: a review of the data since its introduction

Author： Younk Lisa M Mikeladze Maia Davis Stephen N

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.9, 2011-06, pp. : 1439-1451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramlintide for the Treatment of Insulin-Requiring Diabetes Mellitus: Rationale and Review of Clinical Data

By Kruger D.F.

Drugs, Vol. 64, Iss. 13, 2004-01 ,pp. : 1419-1432

Adis International

Access to resources Recommend Favorite

Valsartan plus hydrochlorothiazide: a review of its use since its introduction

By Bains Jujhar Smith William B

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1975-1984

Informa Healthcare

Access to resources Recommend Favorite

Pramlintide a positive adjunct in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

A review of the use of fluticasone furoate since its launch

By Villa Elisa Magnoni Maria Sandra Micheli Dino Canonica Giorgio Walter

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2107-2117

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant pramlintide improves glycaemic control in type 1 diabetes

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite